These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34929358)

  • 1. SARS-CoV-2 seroprevalence in Aden, Yemen: a population-based study.
    Bin-Ghouth AS; Al-Shoteri S; Mahmoud N; Musani A; Baoom NM; Al-Waleedi AA; Buliva E; Aly EA; Naiene JD; Crestani R; Senga M; Barakat A; Al-Ariqi L; Al-Sakkaf KZ; Shaef A; Thabit N; Murshed A; Omara S
    Int J Infect Dis; 2022 Feb; 115():239-244. PubMed ID: 34929358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of ten (10) SARS-CoV-2 rapid serological tests in comparison with WANTAI SARS-CoV-2 ab ELISA in Burkina Faso, West Africa.
    Ouedraogo HG; Zoure AA; Compaoré TR; Ky H; Zida S; Zingué D; Ouedraogo O; Soubeiga ST; Sagna T; Dabiré C; Kambiré D; Zongo D; Yonli AT; Nikiema AR; Nezien D; Bansé GC; Bicaba BW; Perier S; Sawadogo C; Yabre Z; Sangare L
    Virol J; 2023 Mar; 20(1):57. PubMed ID: 36997951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
    Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
    Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of symptomatic, demographical and diet-related comorbidities data with SARS-CoV-2 antibody rapid diagnostic tests during epidemiological surveillance: a cross-sectional study in Jakarta, Indonesia.
    Agustina R; Syam AF; Wirawan F; Widyahening IS; Rahyussalim AJ; Yusra Y; Rianda D; Burhan E; Salama N; Daulay R; Halim ARV; Shankar AH
    BMJ Open; 2021 Aug; 11(8):e047763. PubMed ID: 34376448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
    Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
    Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sars-Cov-2 Infection Screening Using Two Serological Testing Methods.
    Arinola OG; Edem VF; Rahamon SK; Yaqub SA; Fashina AO; Alonge TO
    Niger J Physiol Sci; 2020 Dec; 35(2):117-121. PubMed ID: 34009193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
    Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
    Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
    Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
    Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
    Mboumba Bouassa RS; Péré H; Tonen-Wolyec S; Longo JD; Moussa S; Mbopi-Keou FX; Mossoro-Kpinde CD; Grésenguet G; Veyer D; Bélec L
    J Med Virol; 2021 Apr; 93(4):2196-2203. PubMed ID: 33107601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
    Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
    Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of SARS-CoV-2 antibodies in the general population of Oman: results from four successive nationwide sero-epidemiological surveys.
    Al-Abri SS; Al-Wahaibi A; Al-Kindi H; Kurup PJ; Al-Maqbali A; Al-Mayahi Z; Al-Tobi MH; Al-Katheri SH; Albusaidi S; Al-Sukaiti MH; Al Balushi AYM; Abdelgadir IO; Al-Shehi N; Morkos E; Al-Maani A; Al-Rawahi B; Alyaquobi F; Alqayoudhi A; Al-Harthy K; Al-Khalili S; Al-Rashdi A; Al-Shukri I; Al Ghafri TS; Al-Hashmi F; Al Jassasi SM; Alshaqsi N; Mitra N; Al Aamry HS; Shah P; Al Marbouai HH; Al Araimi AH; Kair IM; Al Manji AM; Almallak AS; Al Alawi FK; Vaidya V; Muqeetullah M; Alrashdi H; Al Jamoudi SSN; Alshaqsi A; Al Sharji A; Al Shukeiri H; Al-Abri B; Al-Rawahi S; Al-Lamki SH; Al-Manji A; Al-Jardani A
    Int J Infect Dis; 2021 Nov; 112():269-277. PubMed ID: 34601146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence and characteristics of Coronavirus Disease (COVID-19) in workers with non-specific disease symptoms.
    Javed W; Abidi SHB; Baqar JB
    BMC Infect Dis; 2022 May; 22(1):481. PubMed ID: 35596145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test.
    Andrey DO; Cohen P; Meyer B; Torriani G; Yerly S; Mazza L; Calame A; Arm-Vernez I; Guessous I; Stringhini S; Roux-Lombard P; Fontao L; Agoritsas T; Stirnemann J; Reny JL; Siegrist CA; Eckerle I; Kaiser L; Vuilleumier N;
    Eur J Clin Invest; 2020 Oct; 50(10):e13357. PubMed ID: 32691863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 antibody kinetics in blood donors with a previously positive SARS-CoV-2 antibody test within a seroprevalence survey.
    Levring MB; Holm DK; Nilsson AC; Bauer JM; Jensen IS; Davidsen JR; Rasmussen LD; Sprogøe U; Lillevang ST
    J Med Virol; 2022 Apr; 94(4):1711-1716. PubMed ID: 34845745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
    Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal: a cross-sectional study.
    Meireles P; Amaro J; Pinto da Costa J; Lopes MM; Varandas T; Norton P; Guimarães JT; Severo M; Barros H
    Occup Environ Med; 2021 Sep; 78(9):648-653. PubMed ID: 34193594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A community based seroprevalence of SARS-CoV-2 antibodies in Somali Region, Eastern Ethiopia.
    Yared S; Abera T; Ali SM; Muhummed AM; Ibrahim M; Hussen A; Hattendorf J; Zinsstag J; Tschopp R
    Immun Inflamm Dis; 2024 Jan; 12(1):e1148. PubMed ID: 38270297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and associated characteristics of anti-SARS-CoV-2 antibodies in Mexico 5 months after pandemic arrival.
    Díaz-Salazar C; Sánchez-García A; Rodríguez-Gutiérrez R; Camacho-Ortiz A; Saldívar-Rodríguez D; González-González JG
    BMC Infect Dis; 2021 Aug; 21(1):835. PubMed ID: 34412620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.